J Clin Oncol 2021 May 27
Treatment De-intensification for HPV-Positive Oropharynx Cancer: What Is Currently Acceptable?
Related Questions
Such as those meeting the eligibility criteria for NRG HN002, <10 pack years, HPV+ T1-2N1-2b, T3N0-N2b
New comment by Radiation Oncologist at Genesis Healthcare Partners- San Diego ( April 22, 2024)
Any updates for 2024? De-escalation outside of trial?
New answer by Radiation Oncologist at American Cancer Center (June 21, 2023)
No.
It is still investigational and not standard of care.